Crossmark

CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer

Crossref DOI link: https://doi.org/10.1186/s13014-015-0360-5

Published Online: 2015-02-28

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cai, Gang

Zhu, Ji

Palmer, Joshua D

Xu, Ye

Hu, Weigang

Gu, Weilie

Cai, Sanjun

Zhang, Zhen
License Information

License valid from 2015-02-28
More Information

Article History

Received: 1 July 2014

Accepted: 16 February 2015

First Online: 28 February 2015